Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Praveen S. Hiremath"'
Publikováno v:
AAPS PharmSciTech. 9:1171-1178
The aim of the present investigation was to develop oral controlled release matrix tablet formulations of isoniazid using hydroxypropyl methylcellulose (HPMC) as a hydrophilic release retardant polymer and to study the influence of various formulatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6935b4375539594fe5d8ea65eeb876f8
https://doi.org/10.1208/s12249-008-9159-0
https://doi.org/10.1208/s12249-008-9159-0
Publikováno v:
Recent patents on drug deliveryformulation. 5(1)
Oral combination drug delivery systems have been proven to be highly beneficial and vital in the treatment of several dreadful diseases such as cancer, HIV (AIDS) and tuberculosis. Further, pharmaceutical companies have often explored the strategy of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91a5fe465c5ab763d05887e619d42b43
https://pubmed.ncbi.nlm.nih.gov/21143126
https://pubmed.ncbi.nlm.nih.gov/21143126
Autor:
Praveen S Hiremath
Publikováno v:
Journal of Bioequivalence & Bioavailability.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fac979b2ad419e71c917b807a5a99144
https://doi.org/10.4172/0975-0851.1000035
https://doi.org/10.4172/0975-0851.1000035
Publikováno v:
International journal of pharmaceutics. 380(1-2)
The aim of the present study was to develop proliposomal formulations to enhance the oral bioavailability of exemestane by improving solubility, dissolution and/or intestinal permeability. Proliposomal powder formulations were prepared using differen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78860497db84d42e9f9081bb7015672d
https://pubmed.ncbi.nlm.nih.gov/19616608
https://pubmed.ncbi.nlm.nih.gov/19616608
Publikováno v:
International journal of pharmaceutics. 362(1-2)
The aim of the present investigation was to develop controlled release (C.R.) matrix tablet formulations of rifampicin and isoniazid combination, to study the design parameters and to evaluate in vitro release characteristics. In the present study, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b60b81c2f3b12e5fabd3ef0525b0655
https://pubmed.ncbi.nlm.nih.gov/18640251
https://pubmed.ncbi.nlm.nih.gov/18640251